BGM Group (BGM) Competitors $9.20 +0.06 (+0.60%) As of 10:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BGM vs. ZLAB, MIRM, AKRO, AAPG, ACAD, NAMS, VKTX, LNTH, TLX, and ADMAShould you be buying BGM Group stock or one of its competitors? The main competitors of BGM Group include Zai Lab (ZLAB), Mirum Pharmaceuticals (MIRM), Akero Therapeutics (AKRO), Ascentage Pharma Group International (AAPG), ACADIA Pharmaceuticals (ACAD), NewAmsterdam Pharma (NAMS), Viking Therapeutics (VKTX), Lantheus (LNTH), Telix Pharmaceuticals (TLX), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry. BGM Group vs. Its Competitors Zai Lab Mirum Pharmaceuticals Akero Therapeutics Ascentage Pharma Group International ACADIA Pharmaceuticals NewAmsterdam Pharma Viking Therapeutics Lantheus Telix Pharmaceuticals ADMA Biologics Zai Lab (NASDAQ:ZLAB) and BGM Group (NASDAQ:BGM) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations. Which has more volatility & risk, ZLAB or BGM? Zai Lab has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, BGM Group has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500. Do insiders and institutionals have more ownership in ZLAB or BGM? 41.7% of Zai Lab shares are held by institutional investors. 5.0% of Zai Lab shares are held by insiders. Comparatively, 58.7% of BGM Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor ZLAB or BGM? In the previous week, Zai Lab had 8 more articles in the media than BGM Group. MarketBeat recorded 10 mentions for Zai Lab and 2 mentions for BGM Group. BGM Group's average media sentiment score of 0.83 beat Zai Lab's score of 0.34 indicating that BGM Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zai Lab 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral BGM Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer ZLAB or BGM? Zai Lab presently has a consensus price target of $56.35, suggesting a potential upside of 96.38%. Given Zai Lab's stronger consensus rating and higher possible upside, equities analysts clearly believe Zai Lab is more favorable than BGM Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zai Lab 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.63BGM Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is ZLAB or BGM more profitable? BGM Group has a net margin of 0.00% compared to Zai Lab's net margin of -49.68%. BGM Group's return on equity of 0.00% beat Zai Lab's return on equity.Company Net Margins Return on Equity Return on Assets Zai Lab-49.68% -27.32% -18.85% BGM Group N/A N/A N/A Which has stronger earnings & valuation, ZLAB or BGM? BGM Group has lower revenue, but higher earnings than Zai Lab. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZai Lab$398.99M8.04-$257.10M-$2.04-14.07BGM Group$25.10M35.62-$1.44MN/AN/A SummaryBGM Group beats Zai Lab on 8 of the 14 factors compared between the two stocks. Get BGM Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricBGM GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$893.94M$3.43B$6.17B$10.57BDividend YieldN/A2.30%5.73%4.78%P/E RatioN/A23.3485.8227.46Price / Sales35.62453.83579.16187.21Price / CashN/A46.7037.4661.86Price / Book1.2510.7212.696.82Net Income-$1.44M-$52.58M$3.32B$276.90M7 Day Performance-5.40%1.60%1.24%0.55%1 Month Performance12.00%17.56%11.24%7.90%1 Year Performance20.33%17.09%75.84%40.38% BGM Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGMBGM Group0.7146 of 5 stars$9.20+0.6%N/A+20.3%$893.94M$25.10M0.00298Gap DownZLABZai Lab2.7826 of 5 stars$33.00-0.9%$56.35+70.8%+18.6%$3.69B$398.99M-16.181,869News CoveragePositive NewsMIRMMirum Pharmaceuticals2.9163 of 5 stars$73.15+0.9%$76.50+4.6%+91.9%$3.67B$429.16M-60.37140Analyst RevisionAKROAkero Therapeutics3.6944 of 5 stars$45.72-0.7%$81.14+77.5%+79.1%$3.66BN/A-22.8930Insider TradeAAPGAscentage Pharma Group InternationalN/A$39.15-1.8%N/AN/A$3.65B$134.35M0.00600ACADACADIA Pharmaceuticals4.4554 of 5 stars$21.57-0.1%$29.12+35.0%+45.8%$3.64B$1.02B16.22510Analyst ForecastNAMSNewAmsterdam Pharma1.4046 of 5 stars$32.35-0.4%$42.00+29.8%+112.9%$3.64B$45.56M-19.934News CoverageVKTXViking Therapeutics3.9783 of 5 stars$31.65-2.0%$86.42+173.1%-46.3%$3.55BN/A-20.6420Upcoming EarningsGap UpLNTHLantheus4.5659 of 5 stars$52.12-1.1%$85.50+64.1%-49.5%$3.55B$1.53B13.87700Trending NewsAnalyst RevisionTLXTelix Pharmaceuticals4.2825 of 5 stars$9.95-2.3%$21.00+111.2%N/A$3.37B$516.72M0.00N/ATrending NewsAnalyst RevisionGap DownADMAADMA Biologics3.6355 of 5 stars$14.060.0%$27.67+96.7%-9.0%$3.35B$426.45M16.31530News Coverage Related Companies and Tools Related Companies ZLAB Competitors MIRM Competitors AKRO Competitors AAPG Competitors ACAD Competitors NAMS Competitors VKTX Competitors LNTH Competitors TLX Competitors ADMA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGM) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BGM Group Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BGM Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
